Results 161 to 170 of about 1,158 (177)

Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome

Journal of Parenteral and Enteral Nutrition, 2018
Kishore Iyer
exaly  

Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study

Clinical Nutrition, 2020
Stéphane M. Schneider, S Layec, P Beau
exaly  

Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon-Like Peptide-2 (GLP-2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects

Journal of Clinical Pharmacology, 2008
Hamim Zahir
exaly  

Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome

Journal of Parenteral and Enteral Nutrition, 2017
Stéphane M. Schneider, Thomas R. Ziegler, Palle B. Jeppesen   +2 more
exaly  

Teduglutide

Reactions Weekly, 2015
openaire   +1 more source

Dose-dependent elevation in amylase and lipase in response to teduglutide administration

Clinical Case Reports (discontinued), 2019
Dong Wook Kim
exaly  

Immunosuppressants/teduglutide

Reactions Weekly, 2019
openaire   +1 more source

Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease.

Inflammatory Bowel Diseases, 2010
John Fang
exaly  

Teduglutide/warfarin

Reactions Weekly, 2018
openaire   +1 more source

Population Pharmacokinetics of Teduglutide Following Repeated Subcutanenous Administrations in Healthy Participants and in Patients With Short Bowel Syndrome and Crohn's Disease

Journal of Clinical Pharmacology, 2010
exaly